Stockreport

Neovasc's Tiara™ for Treatment of Mitral Regurgitation and Neovasc Reducer™ for Treatment of Refractory Angina Featured in Multiple Presentations at TCT 2019 Conference

Neovasc Inc. - Common Shares  (NVCN) 
Last neovasc inc. - common shares earnings: 3/30 04:08 pm Check Earnings Report
US:NASDAQ Investor Relations: neovasc.com/neovasc-investment/overview
PDF NASDAQ, TSX: NVCN VANCOUVER, Sept. 30, 2019 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally inva [Read more]